23 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design.

Genzyme
Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication.

Genzyme
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.

Genzyme
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication.

Genzyme
Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.

Genzyme
Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.

Genzyme
Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication.

Genzyme
Discovery of novel sphingosine kinase-1 inhibitors. Part 2.

Genzyme
Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.

Genzyme
Discovery of novel sphingosine kinase 1 inhibitors.

Genzyme
Discovery of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid diamides that increase CFTR mediated chloride transport.

Genzyme
CAMPTOTHECIN DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

Simcere Zaiming Pharmaceutical Co.
Imidazopyridinone compound

Kissei Pharmaceutical
NOVEL BIPHENYL DERIVATIVE AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF

Xi'An Xinton Pharmaceutcal Research
SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF

Bayer Aktiengesellschaft
JAK kinase inhibitor and preparation method and use thereof

Shanghai Longwood Biopharmaceuticals
Amino acid compounds with unbranched linkers and methods of use

Pliant Therapeutics
Maslinic and oleanolic acids derivatives for treating SARS-CoV-2 infection

King Abdulaziz University
Methods of treating mental disorders

University of California
(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment

Bayer Intellectual Property
Protease inhibitors

Medivir
Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.

University of Colorado